The “Artificial Intelligence Clinical Genomics Interpretation Market Report 2025” reveals significant growth in the AI-driven genomics sector, with the market projected to increase from $1.35 billion in 2024 to $1.74 billion in 2025, reflecting a CAGR of 28.5%. Key drivers include the rising adoption of AI in healthcare, demand for personalized medicine, and enhanced computational power for genomic data analysis. By 2029, the market is expected to reach $4.68 billion, fueled by AI genomic tools, cloud-based analytics, and government funding for genomics research. Trends influencing growth include advancements in predictive analytics and the integration of AI with electronic health records. Major companies, such as Illumina and GeneDx, are investing in scalable innovations for genomic studies, thus enhancing diagnostic accuracy. North America leads the market, while Asia-Pacific is anticipated to be the fastest-growing region. For comprehensive insights, visit ResearchAndMarkets.com.
Source link
